Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Additional thoughts about the 148 response to USPTO

Not feuding. I simply posted a light-hearted ironic observation as in return was threatened with banishment. I guess it's MY aggressiveness, lol.

But your post brings up a good question. What WILL solve PTSC's problems?

  • Is it more licensiing?
  • Fewer BOD members?
  • Lawsuits with the business partner?
  • Banishing posters who focus on reality?
  • Non-Disclosure of company activities / information?
  • Cutting back on PR's?
  • Rarely responding to Investor inquiries even with a simple acknowlegement?
  • High tech Virtual Shareholder meetings?
  • Continue to highly compensate BOD members and Management for poor ROI?
  • etc. etc. etc.

I'm sure you're as interested as most of us. Aside from the above steps that our BOD and Management are/have taken, what is their game plan? Seems to be "hope TPL wins a court battle". Anything further that you see?

Share
New Message
Please login to post a reply